So how do you explain SCI NAVs ranging from -12% to +6% YtD?
Because everyone has their own way of calculating it!
True story. Some add more or fewer fees. Some want to stick to market reality, while others smooth things out a bit more. And depending on the country, valuations are not equally rigorous.
Take one of the best performers of the year: Silver Avenir.
What sorcery is this?
The fund, managed by Arkea Reim, buys homes as “viager” sales without an annuity: the occupants stay in their home for life, and the buyer gets it when they die. The sales literature specifies a discount of around 30%.
In Q1 2023, the SCI showed a +1.49% performance, with 90 properties acquired for €68M. And that is where the subtlety lies.
For example, the SCI buys a lovely house on the Gulf of Morbihan, in Brittany, at €5.7K per m², when the valuer puts it at €10.5K, a 46% discount. Et voilà. The performance is on the balance sheet!
To be clear: the SCI’s performance is in no way tied to a real market or real sales, but to potential capital gains while waiting for the occupants to die. Arkea is even thoughtful enough to tell us they have 12.3 years left to live on average.
Still, it hugely distorts comparisons with other funds, which value a current resale price, not a hoped-for capital gain or a discount.